ATC Group: B01AB05 Enoxaparin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B01AB05 in the ATC hierarchy

Level Code Title
1 B Blood and blood forming organs
2 B01 Antithrombotic agents
3 B01A Antithrombotic agents
4 B01AB Heparin group
5 B01AB05 Enoxaparin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
PAREN - Parenteral 2,000 [iU]

Active ingredients in B01AB05

Active Ingredient Description
Enoxaparin

Enoxaparin is a LMWH with a mean molecular weight of approximately 4,500 daltons, in which the antithrombotic and anticoagulant activities of standard heparin have been dissociated. The drug substance is the sodium salt and has a high anti-Xa activity.

Related product monographs

Title Information Source Document Type  
AROVI 2,000 IU Solution for injection in pre-filled syringe Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
Clexane pre-filled syringes Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CRUSIA Solution for injection Health Products Regulatory Authority (ZA) MPI, Generic
GHEMAXAN Solution for injection Health Products Regulatory Authority (IE) MPI, EU: SmPC
INHIXA 2,000 IU Solution for injection in pre-filled syringe Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
LOVENOX Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
NOXFIBRA Solution for injection Web Search MPI, Generic

Medicines in this ATC group

United States (US)

Albania (AL)

Australia (AU)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Finland (FI)

France (FR)

Hong Kong (HK)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.